Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy.
Pan Y, Wu X, Liu L, Zhao C, Zhang J, Yang S, Pan P, Huang Q, Zhao XZ, Tian R, Rao L.
Pan Y, et al. Among authors: zhao xz.
Adv Healthc Mater. 2024 May;13(13):e2400068. doi: 10.1002/adhm.202400068. Epub 2024 Feb 15.
Adv Healthc Mater. 2024.
PMID: 38320299